Compile Data Set for Download or QSAR
Report error Found 309 Enz. Inhib. hit(s) with all data for entry = 10258
TargetSomatostatin receptor type 3(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523757(US11136312, Compound MM-I-87)
Affinity DataEC50:  0.249nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 3(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523756(US11136312, Compound MM-I-83)
Affinity DataEC50:  0.276nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 3(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523754(US11136312, Compound MM-I-66)
Affinity DataEC50:  0.585nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 3(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523801(US11136312, Compound SK-I-128)
Affinity DataEC50:  0.619nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523801(US11136312, Compound SK-I-128)
Affinity DataKi:  0.632nMAssay Description:Competitive radioligand binding experiments were performed using MEMBRANE TARGET Systems (Perkin-Elmer, Boston, Mass.) for human somatostatin recepto...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523803(US11136312, Compound SK-I-132)
Affinity DataKi:  0.646nMAssay Description:Competitive radioligand binding experiments were performed using MEMBRANE TARGET Systems (Perkin-Elmer, Boston, Mass.) for human somatostatin recepto...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523757(US11136312, Compound MM-I-87)
Affinity DataKi:  0.673nMAssay Description:Competitive radioligand binding experiments were performed using MEMBRANE TARGET Systems (Perkin-Elmer, Boston, Mass.) for human somatostatin recepto...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523770(US11136312, Compound SK-I-124)
Affinity DataKi:  0.707nMAssay Description:Competitive radioligand binding experiments were performed using MEMBRANE TARGET Systems (Perkin-Elmer, Boston, Mass.) for human somatostatin recepto...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 3(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523770(US11136312, Compound SK-I-124)
Affinity DataEC50:  0.725nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523754(US11136312, Compound MM-I-66)
Affinity DataKi:  0.825nMAssay Description:Competitive radioligand binding experiments were performed using MEMBRANE TARGET Systems (Perkin-Elmer, Boston, Mass.) for human somatostatin recepto...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523767(US11136312, Compound SK-I-91)
Affinity DataKi:  0.902nMAssay Description:Competitive radioligand binding experiments were performed using MEMBRANE TARGET Systems (Perkin-Elmer, Boston, Mass.) for human somatostatin recepto...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 3(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523803(US11136312, Compound SK-I-132)
Affinity DataEC50:  0.992nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 3(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523766(US11136312, Compound SK-I-57)
Affinity DataEC50:  1nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523755(US11136312, Compound MM-I-72)
Affinity DataKi:  1.02nMAssay Description:Competitive radioligand binding experiments were performed using MEMBRANE TARGET Systems (Perkin-Elmer, Boston, Mass.) for human somatostatin recepto...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523756(US11136312, Compound MM-I-83)
Affinity DataKi:  1.04nMAssay Description:Competitive radioligand binding experiments were performed using MEMBRANE TARGET Systems (Perkin-Elmer, Boston, Mass.) for human somatostatin recepto...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 3(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523760(US11136312, Compound SK-I-22)
Affinity DataEC50:  1.28nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523760(US11136312, Compound SK-I-22)
Affinity DataKi:  1.42nMAssay Description:Competitive radioligand binding experiments were performed using MEMBRANE TARGET Systems (Perkin-Elmer, Boston, Mass.) for human somatostatin recepto...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 3(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523762(US11136312, Compound SK-I-25)
Affinity DataKi:  1.69nMAssay Description:Competitive radioligand binding experiments were performed using MEMBRANE TARGET Systems (Perkin-Elmer, Boston, Mass.) for human somatostatin recepto...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523759(US11136312, Compound SK-I-16)
Affinity DataKi:  1.72nMAssay Description:Competitive radioligand binding experiments were performed using MEMBRANE TARGET Systems (Perkin-Elmer, Boston, Mass.) for human somatostatin recepto...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523766(US11136312, Compound SK-I-57)
Affinity DataKi:  1.76nMAssay Description:Competitive radioligand binding experiments were performed using MEMBRANE TARGET Systems (Perkin-Elmer, Boston, Mass.) for human somatostatin recepto...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 3(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523759(US11136312, Compound SK-I-16)
Affinity DataEC50:  1.76nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 3(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523762(US11136312, Compound SK-I-25)
Affinity DataEC50:  2.03nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523761(US11136312, Compound SK-I-23)
Affinity DataKi:  2.22nMAssay Description:Competitive radioligand binding experiments were performed using MEMBRANE TARGET Systems (Perkin-Elmer, Boston, Mass.) for human somatostatin recepto...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523764(US11136312, Compound SK-I-55)
Affinity DataKi:  2.79nMAssay Description:Competitive radioligand binding experiments were performed using MEMBRANE TARGET Systems (Perkin-Elmer, Boston, Mass.) for human somatostatin recepto...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 3(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523758(US11136312, Compound MM-I-89)
Affinity DataEC50:  2.80nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523758(US11136312, Compound MM-I-89)
Affinity DataKi:  2.97nMAssay Description:Competitive radioligand binding experiments were performed using MEMBRANE TARGET Systems (Perkin-Elmer, Boston, Mass.) for human somatostatin recepto...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 3(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523802(US11136312, Compound SK-I-130)
Affinity DataEC50:  3.09nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523763(US11136312, Compound SK-I-53)
Affinity DataKi:  3.11nMAssay Description:Competitive radioligand binding experiments were performed using MEMBRANE TARGET Systems (Perkin-Elmer, Boston, Mass.) for human somatostatin recepto...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 3(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523767(US11136312, Compound SK-I-91)
Affinity DataEC50:  3.17nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523738(US11136312, Compound BN-VI-97)
Affinity DataKi:  3.20nMAssay Description:Competitive radioligand binding experiments were performed using MEMBRANE TARGET Systems (Perkin-Elmer, Boston, Mass.) for human somatostatin recepto...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 3(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523755(US11136312, Compound MM-I-72)
Affinity DataEC50:  3.32nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523765(US11136312, Compound SK-I-56)
Affinity DataKi:  3.33nMAssay Description:Competitive radioligand binding experiments were performed using MEMBRANE TARGET Systems (Perkin-Elmer, Boston, Mass.) for human somatostatin recepto...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523802(US11136312, Compound SK-I-130)
Affinity DataKi:  3.72nMAssay Description:Competitive radioligand binding experiments were performed using MEMBRANE TARGET Systems (Perkin-Elmer, Boston, Mass.) for human somatostatin recepto...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 3(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523742(US11136312, Compound SM-I-50)
Affinity DataEC50:  4.35nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523734(US11136312, Compound BN-VI-56)
Affinity DataKi:  5.09nMAssay Description:Competitive radioligand binding experiments were performed using MEMBRANE TARGET Systems (Perkin-Elmer, Boston, Mass.) for human somatostatin recepto...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523768(US11136312, Compound SK-I-105)
Affinity DataKi:  5.13nMAssay Description:Competitive radioligand binding experiments were performed using MEMBRANE TARGET Systems (Perkin-Elmer, Boston, Mass.) for human somatostatin recepto...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523742(US11136312, Compound SM-I-50)
Affinity DataKi:  5.54nMAssay Description:Competitive radioligand binding experiments were performed using MEMBRANE TARGET Systems (Perkin-Elmer, Boston, Mass.) for human somatostatin recepto...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 3(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523765(US11136312, Compound SK-I-56)
Affinity DataEC50:  5.63nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 3(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523763(US11136312, Compound SK-I-53)
Affinity DataEC50:  5.97nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 3(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523764(US11136312, Compound SK-I-55)
Affinity DataEC50:  6.02nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 3(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523738(US11136312, Compound BN-VI-97)
Affinity DataEC50:  6.08nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 3(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523768(US11136312, Compound SK-I-105)
Affinity DataEC50:  6.65nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523746(US11136312, Compound SM-I-92)
Affinity DataKi:  6.98nMAssay Description:Competitive radioligand binding experiments were performed using MEMBRANE TARGET Systems (Perkin-Elmer, Boston, Mass.) for human somatostatin recepto...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 3(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523734(US11136312, Compound BN-VI-56)
Affinity DataEC50:  7.26nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 3(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523761(US11136312, Compound SK-I-23)
Affinity DataEC50:  7.27nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523733(US11136312, Compound BN-VI-61)
Affinity DataKi:  7.74nMAssay Description:Competitive radioligand binding experiments were performed using MEMBRANE TARGET Systems (Perkin-Elmer, Boston, Mass.) for human somatostatin recepto...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 4(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523798(US11136312, Compound AH.2.182)
Affinity DataKi:  8.39nMAssay Description:Competitive radioligand binding experiments were performed using MEMBRANE TARGET Systems (Perkin-Elmer, Boston, Mass.) for human somatostatin recepto...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 3(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523793(US11136312, Compound AH.2.165)
Affinity DataEC50:  8.41nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 3(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523743(US11136312, Compound SM-I-55)
Affinity DataEC50:  8.81nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

TargetSomatostatin receptor type 3(Human)
Board of Trustees of The Southern Illinois University

US Patent
LigandPNGBDBM523798(US11136312, Compound AH.2.182)
Affinity DataEC50:  10nMAssay Description:Measurement of forskolin stimulated inhibition of cAMP was performed via time-resolved fluorescence resonance energy transfer (TR-FRET) LANCE assay (...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/27/2022
Entry Details
US Patent

Displayed 1 to 50 (of 309 total ) | Next | Last >>
Jump to: